NervGen Pharma Corp. (NGEN.V)

6.02 +0.17 (+2.91%) CAD  |  TSXV  |  Feb 20, 16:00
More

NervGen Pharma EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for NGEN.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Arch Biopartners, Inc. Upgrade
Biocure Technology, Inc. Upgrade
Resverlogix Corp. Upgrade
Microbix Biosystems, Inc. Upgrade
Theratechnologies, Inc. Upgrade